Cancer Science & Therapy

Joint Event on 4^th Annual Conference on Preventive Oncology & 4^th Annual Conference on Gynecologic Oncology, Reproductive Disorders Maternal-Fetal Medicine & Obstetrics

July 18-19, 2018 | Atlanta, USA

Keynote

• Dopamine receptor type 1 (D1R) in breast cancer: Expression, signaling and therapeutic applications

  Nira Ben-Jonathan

  PDF HTML

• Clinical application of 8 unique beneficial effects of individually determined optimal dose of vitamin D3 for safe, effective treatment of cancer as well as prevention of possible cancer infection due to mixed infection

  Yoshiaki Omura

  PDF HTML

• Chemopreventive nutraceuticals: What, why and how

  Oroma Beatrice Nwanodi

  PDF HTML

• Nanoparticle delivery of cancer therapeutic RNAs in vivo

  John F McDonald

  PDF HTML

• Inhibition of cisplatin resistant ovarian cancer cell growth both in vitro and in mouse xenograft tumor via autophagy activation, angiogenesis inhibition and targeting HIF-1α and SNAIL1

  Alok De

  PDF HTML

• Chemopreventive nutraceuticals by phytochemical classification

  Oroma Beatrice Nwanodi

  PDF HTML

• Immunological properties of NSC-631570 (Ukraine) - The anti-cancer preparation on basis of greater Celandine alkaloids

  Wassil Nowicky

  PDF HTML

• Our effort to make estrogen receptor positive breast cancer a history

  Sandip K Mishra

  PDF HTML

• Paraneoplastic antigens as biomarkers for early detection of ovarian cancer

  Michael A Tainsky

  PDF HTML